Praxis Precision Medicines and Remagine Labs Announce Strategic Collaboration to Develop Transdermal Ulixacaltamide for Essential Tremor

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/8/2026

1. IONQ
2. SPY
3. IONS
4. ROIV
5. AAPL
6. ACN
7. AZN
8. ORCL
9. HOOD
10. QCOM

Go back to Praxis Precision Medicines and Remagine Labs Announce Strategic Collaboration to Develop Transdermal Ulixacaltamide for Essential Tremor
(NASDAQ: PRAX) Delayed: 352.74 +0.93 (0.26%)
Previous Close $351.81    52 Week High $ 
Open $342.25    52 Week Low $ 
Day High $356.29    P/E N/A 
Day Low $339.50    EPS $ 
Volume 131,565